Avenir Corp - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Avenir Corp ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$5,108,706
-47.7%
2,717,397
-0.1%
0.48%
-44.2%
Q2 2023$9,763,838
+13.4%
2,719,732
+6.4%
0.86%
+5.2%
Q1 2023$8,612,214
+127.1%
2,555,553
+4.4%
0.82%
+114.5%
Q4 2022$3,792,988
+20.5%
2,447,089
+5.7%
0.38%
+13.8%
Q3 2022$3,148,000
-33.6%
2,314,854
+6.9%
0.33%
-26.3%
Q2 2022$4,741,000
-31.7%
2,164,999
-0.5%
0.45%
-18.4%
Q1 2022$6,943,000
-7.3%
2,176,509
+21.8%
0.56%
-3.8%
Q4 2021$7,489,000
-33.9%
1,787,275
+28.1%
0.58%
-39.4%
Q3 2021$11,331,000
+9.8%
1,395,385
+2.1%
0.95%
+16.1%
Q2 2021$10,317,000
+231.2%
1,366,549
+280.8%
0.82%
+204.8%
Q1 2021$3,115,000
+89.0%
358,870
+73.6%
0.27%
+71.3%
Q4 2020$1,648,000
+8.6%
206,740
+8.7%
0.16%
-0.6%
Q3 2020$1,517,000
-8.6%
190,240
+13.4%
0.16%
-16.4%
Q2 2020$1,660,000
+42.6%
167,720
+11.4%
0.19%
+19.6%
Q1 2020$1,164,000
+100.7%
150,6000.0%0.16%
+167.8%
Q4 2019$580,000
-23.5%
150,6000.0%0.06%
-25.3%
Q3 2019$758,000
-21.0%
150,600
+3.6%
0.08%
-21.0%
Q2 2019$960,000
+45.5%
145,300
+66.6%
0.10%
+42.9%
Q1 2019$660,000
+7.0%
87,240
+14.2%
0.07%
-9.1%
Q4 2018$617,000
+13.2%
76,390
+80.8%
0.08%
+28.3%
Q3 2018$545,000
+54.0%
42,255
+36.0%
0.06%
+50.0%
Q2 2018$354,00031,0700.04%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders